AbbVie Reports Third-Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall St set to open higher as tech rebounds, Micron earnings eyed
- Brent hits lowest since before start of Iran war on expectations of smoother oil flows via Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Stay long AI-capex winners into the peak, Stifel says despite bubble fears
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
AbbVie (ABBV) Raises Quarterly Dividend 12.3% to $0.64; 4.2% Yield
October 28, 2016 7:45 AM EDTAbbVie (NYSE: ABBV) declared a quarterly dividend of $0.64 per share, or $2.56 annualized. This is a 12.3% increase from the prior dividend of $0.57.
The dividend will be payable on February 15, 2017, to stockholders of record on January 13, 2017, with an ex-dividend date of January 11,... More
AbbVie (ABBV) Raises Quarterly Dividend 12.3% to $0.64; 4.2% Yield
October 28, 2016 7:45 AM EDTAbbVie (NYSE: ABBV) declared a quarterly dividend of $0.64 per share, or $2.56 annualized. This is a 12.3% increase from the prior dividend of $0.57.
The dividend will be payable on February 15, 2017, to stockholders of record on January 13, 2017, with an ex-dividend date of January 11,... More
AbbVie (ABBV) Tops Q3 EPS by 1c; Boosts FY16 EPS Outlook
October 28, 2016 7:44 AM EDTAbbVie (NYSE: ABBV) reported Q3 EPS of $1.21, $0.01 better than the analyst estimate of $1.20. Revenue for the quarter came in at $6.43 billion versus the consensus estimate of $6.56 billion.
Global HUMIRA sales increased 11.3 percent on a reported basis. Operational HUMIRA sales increased 12.1 percent, excluding a... More